Frontlight ResearchEarly access
Pancreatic cancer trials in Italy
65 of 93 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Bergamo, Genova, Naples, Verona
- Age
- 18 years and over
- People
- 890 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - Phase 3Taking peopleStudy of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- Milan, Padova, Pisa, Rome, Rozzano, Tricase, Verona
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07491445 · EU 2025-525088-34-00 - Phase 2Taking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Bologna, Brescia, Milan, Naples, Siena, Verona
- Age
- 12 years and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - Phase 3Taking peopleA Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- Bologna, Brescia, Candiolo, Foggia, Milan, Naples, Pisa, Roma, Rome, Rozzano, Verona
- Age
- 18 years and over
- People
- 588 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07522073 - Phase 3Not yet taking people in ItalyLow-dose cyclophosphamide maintenance after neoadjuvant systemic chemotherapy and surgery to eradicate microscopic residual disease in PDAC
- Where
- Acquaviva delle Fonti, Bergamo, Foggia, Meldola, Milan, Padova, Rome, Tricase, Verona
- Age
- 18 years to 64 years
- People
- 238
- Run by
- Associazione Italiana Per Lo Studio Del Pancreas
See details and how to join2026-526296-28-00 - Phase 1/2Taking peopleA Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Where
- Aviano, Milan, Rome, Rozzano
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Bayer
See details and how to joinNCT06914128 · EU 2025-520623-24-00 - Phase 3Not yet taking people in ItalyAtebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- Bari, Bologna, Florence, Meldola, Milan, Naples, Padova, Pavia, Pesaro, Pisa, Verona
- Age
- 18 years and over
- People
- 570 worldwide
- Run by
- Immuneering Corporation
See details and how to joinNCT07562152 · EU 2026-525617-31-00 - Phase 3Taking peopleStudy of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- Where
- Florence, Padova
- Age
- 18 years and over
- People
- 670 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07621718 - Phase 1Taking peopleA Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Where
- Milan
- Age
- 18 years and over
- People
- 575 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06400472 · EU 2024-511238-11-00 - Phase 2Taking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Milan, Reggio Emilia, Rome
- Age
- 18 years and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - Phase 2Taking peopleA Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Where
- Bergamo, Milan, Naples, Perugia, Siena
- Age
- 18 years and over
- People
- 254 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07492680 - Phase 3Not yet taking people in ItalyA Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Where
- Bergamo, Brescia, Catania, Florence, Foggia, Genoa, Milan, Padova, Parma, Pisa, Ravenna, Reggio Emilia, Rome, Rozzano, Siena, Verona, Vicenza
- Age
- 18 years and over
- People
- 614 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07409272 · EU 2025-523684-38-00 - Phase 2/3Taking peopleZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Aviano, Bologna, Meldola, Milan, Naples, Orbassano to, Palermo, Roma
- Age
- 18 years and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00 - Phase 1/2Taking peopleA Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Where
- Milan, Rome
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06428409 · EU 2023-508703-21-00 - Phase 1/2Taking peopleBOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours
- Where
- Milan, Naples, Pisa
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Bold Therapeutics, Inc.
See details and how to joinNCT04421820 · EU 2024-517500-11-00 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Candiolo, Milan, Naples, Rome, Rozzano
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 3Taking peopleStudy of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Where
- Milan, Naples, Padova, Pisa, Rome, Verona
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07252232 · EU 2025-523495-23-00 - Phase 3Not yet taking people in ItalyPhase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
- Where
- Bologna, Florence, Foggia, Meldola, Milan, Modena, Naples, Padova, Pisa, Rome, Rozzano, Tricase, Verona
- Age
- 18 years and over
- People
- 233 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2025-524969-24-00 - No phaseNot yet taking people in ItalyTargeted Nutritional Intervention (HMB, Arginine, Glutamine) in Patients With Pancreatic Cancer
- Where
- Roma
- Age
- 18 years and over
- People
- 24
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07883161 - Phase 1/2Taking peopleA Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Where
- Milan, Pisa, Roma
- Age
- 18 years and over
- People
- 346 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06885034 - Phase 2/3Not yet taking people in ItalyA Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination with Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants with First-Line Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- Milan, Rozzano, Verona
- Age
- 18 years and over
- People
- 194 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2025-522563-15-00 - Phase 1Taking peopleKO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Where
- Bologna, Candiolo, Naples, Rozzano, Verona
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06026410 · EU 2024-513285-19-00 - Phase 2/3Taking peopleA Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Where
- Ancona, Florence, Foggia, Milan
- Age
- 18 years and over
- People
- 982 worldwide
- Run by
- Pfizer
See details and how to joinNCT06989437 · EU 2025-522093-36-00 - Phase 1/2Not yet taking people in ItalySNIPER-LTFU: Long-term follow-up study of patients administered with RR001 in the interventional Parent SNIPER study
- Where
- Modena
- Age
- 18 years and over
- People
- 18
- Run by
- Eir Biotherapies S.r.l.
See details and how to join2026-525714-59-00 - Phase 1/2Not yet taking people in ItalyPhase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Pancreatic Cancer (Substudy PDAC)
- Where
- Ancona, Milan, Naples, Padova, Pisa, Reggio Emilia, Rome
- Age
- 18 years and over
- People
- 26 worldwide
- Run by
- Merck Healthcare KGaA
See details and how to join2024-517819-74-00